/CNW/ - Takeda Canada Inc. ("Takeda") is pleased to announce that TAKHZYRO® (lanadelumab), the first approved monoclonal antibody for the treatment of.
/PRNewswire/ Modern Mill, manufacturer of innovative wood alternative ACRE, announces that its ACRE product line has been selected to receive a Best of.